Glemanserin

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGlemanserin
Drug Alias Name格来色林glemanserinaglemanserinumMDL-11939MDL-11939A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2 (5-HT2) receptor antagonists
TargetsSerotonin 2 (5-HT2) receptor
Therapy Area/IndicationsAnxiety
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsAnxiety

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG